Environmental, social and Governance Report
CONTENTS
About Haiyao 1 green development 20 about this report 2 environmental management system 21 chairman’s speech 3 promoting resource recycling 21 company overview 4 strengthening cleaner production 22 corporate governance 6 23 people-oriented
Governance structure 7
ESG management framework 9 protection of employees’ rights and interests 24 stakeholder communication 10 promotion of employees’ development 24 occupational health protection 24 reform and development 11 colorful employee activities 25 precise implementation and operation 12
Optimize the marketing mechanism 13 public welfare charity 26 innovation driven development 14 Rural Revitalization 27 quality and safety 16 enter the community 27 fight against the epidemic 28 strengthen quality management 17 evaluation of drugs after listing 17 safety production guarantee 18 customer service guarantee 19 sustainable supply chain management 19
2021 Environmental, Social and Governance Report
About Haiyao about us
ESG report description of the overview of this report
In this environmental, social and Governance Report (hereinafter referred to as the report), unless the context otherwise requires, the following words have the following meanings:
“ESG report”) means Hainan Haiyao Co.Ltd(000566) issued:
Cloth’s first ESG report mainly introduces the company’s environment
Concept, practice and effectiveness of environmental, social and governance. CSRC refers to the China Securities Regulatory Commission
Content and scope Shenzhen stock exchange refers to Shenzhen Stock Exchange
Unless otherwise stated, the groups covered by this ESG Report
The scope of organization is Hainan Haiyao Co.Ltd(000566) and its subsidiaries. Xinxing Jihua Group Corporation Limited(601718) in this report refers to Xinxing Jihua Group Corporation Limited(601718) Co., Ltd
The time range covered is the same as the company’s 2021 annual report
Consistent, from January 1 to December 3, 2021
11 days (hereinafter referred to as the “reporting period”). For the purpose of strengthening this pharmaceutical holding, it refers to Xinxing Jihua pharmaceutical Holding Co., Ltd
The comparability of the report, and some contents exceed the above requirements as needed
Describe the time range. Huatong industry refers to Hainan Huatong Industry Co., Ltd
Hainan Haiyao Co.Ltd(000566) . Company refers to Hainan Haiyao Co.Ltd(000566)
Preparation criteria
This report refers to Haikou Pharmaceutical Factory Co., Ltd. according to the Shanghai pharmaceutical factory issued by Shenzhen Stock Exchange
Municipal guidelines on corporate social responsibility and self-discipline supervision of listed companies
Prepared by the regulatory guidelines and the self regulatory guidelines for listed companies. Tiandi pharmaceutical refers to Chongqing Tiandi Pharmaceutical Co., Ltd
Preparation description Jiangsu Pujian refers to Jiangsu Pujian Pharmaceutical Co., Ltd
The information involved in this report comes from
The official documents and statistical reports of the company refer to Jiangsu hankuo biological Co., Ltd
The monetary amount is measured in RMB. company
The directors, supervisors and senior management ensure that the ESG report refers to Yancheng Kaiyuan Pharmaceutical Chemical Co., Ltd
The content of the report is true, accurate and complete, and there is no falsehood
False records, misleading statements or material omissions. Shanghai lishengte refers to the release form of Shanghai lishengte Medical Technology Co., Ltd. Lianqiao Yaodu refers to Hunan Lianqiao Yaodu Pharmaceutical Co., Ltd
This report is on the company’s website
http://www.haiyao.com.cn. And tide GMP refers to the certification of drug production quality management practices
information net http://www.cn.info.com.cn. conduct
release. GSP refers to the certification of drug operation quality management practices
Strengthen management and control, increase efficiency and take responsibility for promoting development
Looking back on 2021, Hainan Haiyao Co.Ltd(000566) has gone through an extraordinary and challenging year.
The company actively responds
To meet the dual challenges brought by the reform of the national medical and health system and the covid-19 epidemic, we anchored the “one main and multiple” development strategy, strengthened production and operation control, and continued
Continue to optimize the layout of the industrial chain, steadily promote projects under construction, accelerate the progress of products under research, strengthen the construction of marketing resource channels, and effectively prevent heavy winds
Insurance, organize and carry out the activity of “learning party history, increasing confidence, improving performance and promoting development”, and give full play to the leadership of the Party committee “taking direction, managing the overall situation and promoting implementation”
We have taken multiple measures to promote reform and development, firmly stabilized the basic situation of production and operation, and laid a solid foundation for accelerating the strategic development plan of the 14th five year plan
A good foundation has been laid.
In the new year, we will adhere to the main line of strengthening Party building, stabilizing operation and promoting development, adhere to using development methods to solve problems in development, and continue to
Accelerate development through adjustment and optimization. We will carry out the theme activity of “I am a party member, I am proud, I am a party member, I take responsibility, I do my duty” and
The special action of “operation compliance management year” has created an all-round entrepreneurial atmosphere of “taking responsibility as pride, focusing on development and striving for joy”
Risk management and control, promote compliance operation, and go all out to achieve Hainan Haiyao Co.Ltd(000566) set objectives and tasks.
In the new year, we will focus more on the main industry, give full play to our advantages, make up for our weaknesses and enhance the core competitiveness of enterprises. Focus on tamping the chemical medicine sector
Basics. Strengthen the industrial chain reinforcement and chain strengthening of the chemical medicine sector, adhere to the chess layout of intermediates, APIs and preparations, and give full play to the synergy of the industrial chain
And the competitive advantage of the industrial chain. Accelerate the expansion of traditional Chinese medicine products. Seize the development opportunity of national traditional Chinese medicine and focus on the development of Fengliao changweikang traditional Chinese medicine of the company
Varieties, carry out innovative research on the inheritance of traditional Chinese medicine, enrich the product group of traditional Chinese medicine, and lead the comprehensive revitalization of Hainan Li pharmaceutical industry. Strengthen R & D investment and scientific research management
Manage. According to the plan, we will accelerate the consistency evaluation and the clinical research of flufenidone capsules and pinegabine tablets, a class 1 new drug of two national chemical drugs.
Choose the opportunity to enter the field of biopharmaceutical. Combined with the company’s resource endowment, carry out relevant demonstration work, timely build a biopharmaceutical platform, and strive to seek cross company cooperation
More and more development.
2022 has entered the April day of the world. The time for Hainan Haiyao Co.Ltd(000566) reform and development cannot wait. We must persevere even if the road ahead is difficult. We
Firmly believe that you can go wherever you want! Only by continuous struggle can we have a promising future. We will adhere to the thought of socialism with Chinese characteristics in the Xi Jinping new era
For guidance, enhance the guarantee ability of protecting the army for the people and responding to public health events, and build Hainan Haiyao Co.Ltd(000566) into a reliable pharmaceutical enterprise for the army and the people
Industry, and constantly show new achievements in promoting Hainan Haiyao Co.Ltd(000566) to achieve high-quality development!
Hainan Haiyao Co.Ltd(000566) party secretary and Chairman
Wang Jianping
ESG report company profile
Hainan Haiyao Co.Ltd(000566) is a comprehensive pharmaceutical enterprise under Pharmaceutical holding, a wholly-owned secondary subsidiary of Xinxing Jihua Group Corporation Limited(601718) , a central enterprise supervised by the state owned assets supervision and Administration Commission of the State Council. Taking protecting human health as its own responsibility, the company is committed to becoming an influential manufacturer of “generic drugs + innovative drugs” of anti infective drugs in China. The innovation system of the company is complete, the R & D pipeline is competitive, and the core products are well-known in the industry. Historical evolution
The company is listed on the Shenzhen Stock Exchange as a pharmaceutical holding company with Hainan
Listing (Stock Code: Haiyao completion strategy)
Hainan Haiyao Co.Ltd(000566) ), a Chinese group, Hainan Haiyao Co.Ltd(000566) Cheng
The first batch of listed pharmaceuticals of the company’s predecessor Haihai company are controlled by central enterprises
Kouchi pharmaceutical factory is a joint-stock manufacturing enterprise, which is also a mixed ownership enterprise in Haikou
Established. Made. The first pharmaceutical industry in southern province has started its development
A listed company. A new journey.
19651992 19942020
Core values
01 R & D
01 take high-end R & D innovation as the core and industrialize R & D achievements in core fields,
Research and development, so as to promote the progress of human health and the sustainable development of the industry
The quality of human life.
02 manufacturing
Guard you and me, take the scientific and technological innovation of the whole industrial chain as the core, and boost the pharmaceutical industry through industrial upgrading
Modernize the health industry within reach, provide high-quality medicine and medical products for health, and improve
Human health level.
03 02 03 business and service
Commercial manufacturing takes the innovation of business model and service model as the core to promote business and service standards
